Flexible Synthesis Scheme and Application of AuNP Surface-Conjugatable Metaiodobenzylguanidine Derivatives for Enhanced Cellular Internalization
Source abstract
Abstract
A synthesis of two metaiodobenzylguanidine (MIBG) derivatives is reported: N -[4-(guanidinomethyl)-2-iodophenyl]-3-mercaptopropanamide (MIBG-3-MPAM) and N -[4-(guanidinomethyl)phenyl]-3-mercaptopropanamide (BG-3-MPAM). The design of these molecules allows for their conjugation to a wide range of nanocarriers, such as pulsed-laser ablation (PLA)-synthesized gold nanoparticles (AuNPs), which are utilized here to assess uptake into neuroblastoma (NB), HeLa, and HEK cell lines. Through dark-field imaging and quantitative inductively coupled plasma mass spectrometry (qICP-MS), the MIBG derivatives are found to enhance total AuNP uptake in vitro by over 100× at sufficiently high molar ratios across cell lines, and the iodine atom is found to play an important role in further enhancing the uptake efficiency.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Diamond and Carbon-based Materials Research · Nonlinear Optical Materials Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
University of Michigan, Department of Chemistry, 930 N University Ave, Ann Arbor, Michigan 48109, United States
IMRA America, Inc., 1044 Woodridge Avenue, Ann Arbor, Michigan 48105, United States
Funding
National Cancer Institute
References (31)
Show source-provided references
1. 10.1067/mnc.2002.12147110.1067/mnc.2002.121471 ↗
2. 10.1148/rg.201615009910.1148/rg.2016150099 ↗
3. 10.1080/14737140.2017.128523010.1080/14737140.2017.1285230 ↗
4. 10.1002/pbc.2520010.1002/pbc.25200 ↗
5. 10.2967/jnumed.118.21746310.2967/jnumed.118.217463 ↗
6. 10.3390/cancers912017310.3390/cancers9120173 ↗
7. 10.1002/anie.20210196410.1002/anie.202101964 ↗
8. 10.2217/nnm.14.16910.2217/nnm.14.169 ↗
9. 10.1016/j.bbcan.2021.18853210.1016/j.bbcan.2021.188532 ↗
10. 10.1016/j.pdpdt.2021.10269710.1016/j.pdpdt.2021.102697 ↗
11. 10.1002/smll.20120310610.1002/smll.201203106 ↗
12. 10.1002/adhm.20190122310.1002/adhm.201901223 ↗
13. 10.4155/tde.13.810.4155/tde.13.8 ↗
14. 10.1039/C5TB00287G10.1039/C5TB00287G ↗
15. 10.1039/D1RA04054E10.1039/D1RA04054E ↗
16. 10.1021/acs.chemrev.6b0046810.1021/acs.chemrev.6b00468 ↗
17. 10.1016/j.cap.2017.08.00410.1016/j.cap.2017.08.004 ↗
18. 10.2147/IJN.S13783310.2147/IJN.S137833 ↗
19. 10.1002/advs.20160023710.1002/advs.201600237 ↗
20. 10.1021/acs.chemmater.1c0033610.1021/acs.chemmater.1c00336 ↗
21. 10.1038/s41467-020-20276-z10.1038/s41467-020-20276-z ↗
22. 10.3390/ijms2107248010.3390/ijms21072480 ↗
23. 10.1021/acs.accounts.9b0010310.1021/acs.accounts.9b00103 ↗
24. 10.1016/j.colsurfb.2014.06.00110.1016/j.colsurfb.2014.06.001 ↗
25. 10.1039/b712170a10.1039/b712170a ↗
26. 10.1021/acsnano.6b0014210.1021/acsnano.6b00142 ↗
27. 10.1111/j.1471-4159.2006.03717.x10.1111/j.1471-4159.2006.03717.x ↗
28. 10.1074/jbc.273.12.697610.1074/jbc.273.12.6976 ↗
29. 10.1016/j.bioactmat.2020.06.02410.1016/j.bioactmat.2020.06.024 ↗
30. 10.1021/acs.nanolett.7b0302110.1021/acs.nanolett.7b03021 ↗
31. 10.1002/ange.20190234710.1002/ange.201902347 ↗